KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

Gsk (GSK) Inventory Average (2016 - 2025)

Historic Inventory Average for Gsk (GSK) over the last 17 years, with Q3 2025 value amounting to $8.2 billion.

  • Gsk's Inventory Average rose 841.38% to $8.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $8.2 billion, marking a year-over-year increase of 841.38%. This contributed to the annual value of $7.0 billion for FY2024, which is 664.64% up from last year.
  • Per Gsk's latest filing, its Inventory Average stood at $8.2 billion for Q3 2025, which was up 841.38% from $7.8 billion recorded in Q2 2025.
  • In the past 5 years, Gsk's Inventory Average ranged from a high of $8.7 billion in Q3 2021 and a low of $3.6 billion during Q2 2022
  • In the last 5 years, Gsk's Inventory Average had a median value of $7.3 billion in 2024 and averaged $7.0 billion.
  • In the last 5 years, Gsk's Inventory Average plummeted by 5868.59% in 2022 and then surged by 8629.31% in 2023.
  • Over the past 5 years, Gsk's Inventory Average (Quarter) stood at $8.2 billion in 2021, then decreased by 29.73% to $5.8 billion in 2022, then increased by 19.42% to $6.9 billion in 2023, then grew by 8.72% to $7.5 billion in 2024, then increased by 9.28% to $8.2 billion in 2025.
  • Its Inventory Average was $8.2 billion in Q3 2025, compared to $7.8 billion in Q2 2025 and $7.4 billion in Q1 2025.